RESUMO
Visceral leishmaniasis (VL) is the most severe clinical form of leishmaniasis, fatal if untreated. Vaccination is the most cost-effective approach to disease control; however, to date, no vaccines against human VL have been made available. This work examines the efficacy of a novel vaccine consisting of the Leishmania membrane protein KMP11, LEISH-F3+ (a recombinant fusion protein, composed of epitopes of the parasite proteins nucleoside hydrolase, sterol-24-c-methyltransferase, and cysteine protease B), and the sand fly salivary protein LJL143, in two dose ratios. The inclusion of the TLR4 agonist GLA-SE as an adjuvant, and the use of virosomes (VS) as a delivery system, are also examined. In a hamster model of VL, the vaccine elicited antigen-specific immune responses prior to infection with Leishmania infantum. Of note, the responses were greater when higher doses of KMP11 and LEISH-F3+ proteins were administered along with the GLA-SE adjuvant and/or when delivered within VS. Remarkably, hamsters immunized with the complete combination (i.e., all antigens in VS + GLA-SE) showed significantly lower parasite burdens in the spleen compared to those in control animals. This protection was underpinned by a more intense, specific humoral response against the KMP11, LEISH-F3+, and LJL143 antigens in vaccinated animals, but a significantly less intense antibody response to the pool of soluble Leishmania antigens (SLA). Overall, these results indicate that this innovative vaccine formulation confers protection against L. infantum infection, supporting the advancement of the vaccine formulation into process development and manufacturing and the conduction of toxicity studies towards future phase I human clinical trials.
RESUMO
Leishmania infantum causes visceral leishmaniasis (kala-azar), the most severe form of leishmaniasis, which is lethal if untreated. A few years ago, the re-sequencing and de novo assembling of the L. infantum (JPCM5 strain) genome was accomplished, and now we aimed to describe and characterize the experimental proteome of this species. In this work, we performed a proteomic analysis from axenic cultured promastigotes and carried out a detailed comparison with other Leishmania experimental proteomes published to date. We identified 2352 proteins based on a search of mass spectrometry data against a database built from the six-frame translated genome sequence of L. infantum. We detected many proteins belonging to organelles such as glycosomes, mitochondria, or flagellum, as well as many metabolic enzymes and many putative RNA binding proteins and molecular chaperones. Moreover, we listed some proteins presenting post-translational modifications, such as phosphorylations, acetylations, and methylations. On the other hand, the identification of peptides mapping to genomic regions previously annotated as non-coding allowed for the correction of annotations, leading to the N-terminal extension of protein sequences and the uncovering of eight novel protein-coding genes. The alliance of proteomics, genomics, and transcriptomics has resulted in a powerful combination for improving the annotation of the L. infantum reference genome.
Assuntos
Leishmania infantum/genética , Leishmania infantum/metabolismo , Proteoma/genética , Proteoma/metabolismo , Sequência de Aminoácidos , Biologia Computacional/métodos , Genômica/métodos , Leishmaniose Visceral/genética , Leishmaniose Visceral/metabolismo , Chaperonas Moleculares/genética , Chaperonas Moleculares/metabolismo , Anotação de Sequência Molecular/métodos , Peptídeos/genética , Peptídeos/metabolismo , Processamento de Proteína Pós-Traducional/genética , Proteômica/métodos , Proteínas de Protozoários/genética , Proteínas de Protozoários/metabolismo , Proteínas de Ligação a RNA/genética , Proteínas de Ligação a RNA/metabolismo , Espectrometria de Massas em Tandem/métodosRESUMO
Leishmania braziliensis is the etiological agent of American mucosal leishmaniasis, one of the most severe clinical forms of leishmaniasis. Here, we report the assembly of the L. braziliensis (M2904) genome into 35 continuous chromosomes. Also, the annotation of 8395 genes is provided. The public availability of this information will contribute to a better knowledge of this pathogen and help in the search for vaccines and novel drug targets aimed to control the disease caused by this Leishmania species.
Assuntos
Leishmania braziliensis/genética , DNA de Protozoário/genética , Análise de Sequência de DNARESUMO
Molecular chaperones are key components in the maintenance of cellular homeostasis and survival, not only during stress but also under optimal growth conditions. Folding of nascent polypeptides is supported by molecular chaperones, which avoid the formation of aggregates by preventing nonspecific interactions and aid, when necessary, the translocation of proteins to their correct intracellular localization. Furthermore, when proteins are damaged, molecular chaperones may also facilitate their refolding or, in the case of irreparable proteins, their removal by the protein degradation machinery of the cell. During their digenetic lifestyle, Leishmania parasites encounter and adapt to harsh environmental conditions, such as nutrient deficiency, hypoxia, oxidative stress, changing pH, and shifts in temperature; all these factors are potential triggers of cellular stress. We summarize here our current knowledge on the main types of molecular chaperones in Leishmania and their functions. Among them, heat shock proteins play important roles in adaptation and survival of this parasite against temperature changes associated with its passage from the poikilothermic insect vector to the warm-blooded vertebrate host. The study of structural features and the function of chaperones in Leishmania biology is providing opportunities (and challenges) for drug discovery and improving of current treatments against leishmaniasis.
Assuntos
Leishmania/fisiologia , Chaperonas Moleculares/fisiologia , Proteínas de Protozoários/fisiologia , Estresse Fisiológico/fisiologia , Genoma de Protozoário/genética , Genoma de Protozoário/fisiologia , Proteínas de Choque Térmico/genética , Proteínas de Choque Térmico/fisiologia , Leishmania/genética , Chaperonas Moleculares/genética , Proteínas de Protozoários/genéticaRESUMO
Objetivos. Explorar una nueva diana para el diagnóstico molecular de Leishmania. Materiales y métodos. Se evaluó la utilidad del gen que codifica la proteína de choque térmico de 20kDa (hsp20) para la detección de Leishmania por medio de la reacción en cadena de la polimerasa (PCR).Se normalizó la PCR y se determinaron los parámetros analíticos, así como la validez y seguridad diagnóstica y la concordancia con la PCR-18S. Se evaluó la PCR-hsp20 con ADN obtenido de un grupo de muestras clínicas de distinta procedencia. Resultados. Los parámetros analíticos resultaron adecuados. La sensibilidad obtenida fue de 86% y la especificidad del 100%, la concordancia con el método de referencia resultó buena (ƙ=0,731), lo que apoya su posible uso para el diagnóstico. La posibilidad de identificación posterior de la especie mediante secuenciación del producto amplificado le confiere una ventaja adicional. Conclusiones. Se demuestra la utilidad de este gen como una nueva diana para la detección del género Leishmania. Debido a su potencial, se recomienda mejorar la sensibilidad del procedimiento y realizar su evaluación en diversas regiones endémicas.
Objectives. Explore a new target for molecular diagnosis of Leishmania. Materials and methods. We evaluated the utility of the gene that encodes the heat shock protein 20-kDa (Hsp20) for detecting Leishmania by polymerase chain reaction (PCR). PCR was normalized and analytical parameters were determined, as well as the validity and diagnostic accuracy, and concordance with the PCR - 18S. PCR-Hsp20 with DNA was obtained from a group of clinical samples from different sources. Results. The analytical parameters were adequate. The sensitivity obtained was 86% and the specificity was 100%. The concordance with the reference method was good (Ƙ = 0.731), which supports its potential use for diagnosis. The possibility of subsequent identification of the species by sequencing the amplified product gives an additional advantage. Conclusions. The usefulness of this gene as a new target for the detection of Leishmania was demonstrated. Because of its potential, it is recommended to improve the sensitivity of the method and to evaluate it in different endemic regions.
Assuntos
Leishmania/genética , Leishmaniose/diagnósticoRESUMO
The observation that recovery from infection with Leishmania confers immunity to reinfection suggests that control of leishmaniasis by vaccination may be possible. However, there are no vaccines available at present to control any form of leishmaniasis, despite considerable efforts. Studies of the immunopathogenesis and mechanisms of protective immunity, mainly derived from animal models of experimental leishmaniasis, have defined a number of features that should be met by an effective vaccine. In addition, several antigens have been identified that may be potential vaccine candidates, and molecular biological techniques have made them available as recombinant proteins for second-generation vaccines. Furthermore, molecules present in the saliva of Leishmania-transmitting vectors have been demonstrated as valuable candidates for the development of anti-Leishmania vaccines. This review concentrates on the most promising vaccine candidates and highlights new approaches for the development of vaccines. Finally, based on present knowledge, the future prospects for developing an effective vaccine against the different clinical forms of leishmaniasis are discussed.
Assuntos
Leishmania/imunologia , Leishmaniose/prevenção & controle , Vacinas Protozoárias , Animais , Ensaios Clínicos como Assunto , Cricetinae , Citocinas/fisiologia , Células Dendríticas/imunologia , Suscetibilidade a Doenças , Cães , Humanos , Insetos Vetores/química , Insetos Vetores/parasitologia , Leishmaniose/epidemiologia , Leishmaniose/imunologia , Macrófagos/parasitologia , Camundongos , Camundongos Endogâmicos , Vacinas Protozoárias/imunologia , Psychodidae/química , Psychodidae/parasitologia , Saliva/imunologia , Especificidade da Espécie , Subpopulações de Linfócitos T/imunologia , Vacinas Atenuadas/imunologia , Vacinas de DNA/imunologia , Vacinas de Produtos Inativados/imunologiaRESUMO
Se construyó una genoteca de Leishmania amazonensis en vector de expresión en células eucariotas (pEF1HisA, pEF1HisB, pEF1HisC). Se prepararon 2 subgenotecas con un número aproximado de 500 clones cada una y ratones BALB/c fueron inmunizados con 50 mg/0,1 mL de ADN de cada una; 2 inmunizaciones por vía IM, con 15 d de intervalo fueron realizadas. Grupos de ratones controles fueron inmunizados con ADN del plásmido vacío, con antígeno soluble del parásito (100 mg/0,1 mL) y solución salina fisiológica. Se midió el tamaño de las lesiones durante 12 semanas y al final del experimento, la carga parasitaria en los sitios de lesión fue determinada por el método de microtitulación en placas. Los ratones inmunizados con ADN 1, controlaron el tamaño de las lesiones, así como también los inmunizados con antígenos solubles, lo que alcanzó diferencia estadística (p< 0,05) en relación con el resto de los grupos, cuyas lesiones aumentaron de manera creciente. La carga de parásitos encontrada en los sitios de lesión corroboró los resultados anteriores, encontrando un número de promastigotes significativamente menor en aquellos que habían sido protegidos. Se concluyó que en la subgenoteca ADN1 deben existir genes, o fragmentos de genes, cuya expresión in vivo resulta protectora contra el reto, en el modelo murino empleado
Assuntos
Animais , Camundongos , Leishmania mexicana , Camundongos Endogâmicos BALB C/imunologia , Vacinas de DNARESUMO
In this study, we show that the glucose-regulated protein 94 (GRP94) from Leishmania infantum is a major target for humoral immune response during both visceral (VL) and mucocutaneous leishmaniasis (MCL). Also, the time-course of appearance of anti-GRP94 antibodies along the infection was analysed in hamsters (Mesocricetus auratus) experimentally infected with L. infantum. Remarkably, the reactivity against the Leishmania GRP94 was observed very soon after challenge, at the time of appearance of a humoral response against Leishmania total proteins, and long before that the animals develop clinical symptoms of disease. Therefore, at least for golden hamsters, the reactivity against Leishmania GRP94 is an early marker of infection. Using a collection of synthetic peptides covering the complete sequence of the L. infantum GRP94, we have determined the main linear antigenic determinants recognised by sera from humans, dogs, and hamsters suffering from VL. Four synthetic peptides, located in highly divergent regions of the protein, were found to be immunodominants and recognised by VL sera of these three different origins. We discuss that the prominent antigenicity of Leishmania GRP94 may be related to recent findings involving GRP94, and other heat shock proteins, in relevant immune functions such as tumour immunogenicity and antigen presentation.